Xixue Chen
Overview
Explore the profile of Xixue Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Li J, Tang Y, Chong S, Shang P, Chen X, et al.
J Dermatol
. 2025 Feb;
PMID: 39902526
The treatment of pemphigus vulgaris (PV) often requires long-term systemic corticosteroids. Although new biologicals like rituximab are changing the landscape, traditional immunosuppressants still prevail in many underdeveloped areas. One such...
2.
Li J, Chen X, Zhu X, Shang P, Wang M
J Dermatol Sci
. 2024 Oct;
116(1):24-33.
PMID: 39358056
Background: Dupilumab, a novel therapy targeting the T helper (Th) 2-mediated inflammation, is showing clinical benefits in treating bullous pemphigoid (BP). However, limited research investigated the serum biomarkers that reflect...
3.
Chen X, Zhu Y, Zhang Y
Environ Pollut
. 2024 Jul;
359:124604.
PMID: 39053803
Microplastics (MPs) affect the physicochemical algal-dissolved organic matter properties, indirectly influencing the environmental behavior of contaminants including persistent organic pollutants and heavy metals. Limited research is available on the roles...
4.
Zhang Y, Dang J, Li R, Chen X, Zhu X, Wang M
Acta Derm Venereol
. 2024 Jan;
104:adv11917.
PMID: 38270257
Epidermolysis bullosa acquisita (EBA) rarely develops in childhood. This study retrospectively recruited paediatric patients with EBA (age ≤ 16 years), diagnosed by clinical and histopathological features and results of immunofluorescence,...
5.
Wang S, Wang R, Shang P, Zhu X, Chen X, Zhang G, et al.
J Invest Dermatol
. 2023 Oct;
144(3):585-592.e1.
PMID: 37839777
Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder. Paraneoplastic pemphigus (PNP) is a major complication associated with poor UCD prognosis. However, the genomic profiles and prognostic biomarkers of PNP-associated...
6.
Zhao L, Wang Q, Liang G, Zhou Y, Yiu N, Yang B, et al.
JAMA Dermatol
. 2023 Aug;
159(9):953-960.
PMID: 37531116
Importance: Dupilumab is a theoretically novel therapy for bullous pemphigoid (BP). However, its effectiveness and safety have yet to be confirmed in a large-scale study. Objective: To assess the efficacy...
7.
Wang M, Li J, Shang P, Chong S, Chen Y, Zhao L, et al.
J Dermatol
. 2023 May;
50(10):1347-1352.
PMID: 37248863
Therapy discontinuation of systemic glucocorticoid treatment for pemphigus remains uncertain at the clinical end point of complete remission. The objective of this study was to identify the factors associated with...
8.
Fan B, Tang Y, Chang Y, Chen X, Tu P, Wang M
J Dermatol Sci
. 2023 Jan;
108(3):121-126.
PMID: 36608995
Background: Bullous pemphigoid (BP) mostly involves elderly patients. The diagnosis of BP requires special immunological tests, which makes some patients unable to be diagnosed and treated timely. Objective: The accuracy...
9.
Fan B, Chen X, Zhu X, Wang M
J Dermatolog Treat
. 2022 Aug;
34(1):2113756.
PMID: 35972213
No abstract available.
10.
Wang X, Wang R, Bu D, Wang L, Zhang Y, Chang Y, et al.
Front Immunol
. 2022 Aug;
13:886226.
PMID: 35911677
Paraneoplastic pemphigus (PNP) is an autoimmune bullous disease associated with underlying neoplasms and characterized by antibodies against desmoglein 3 (Dsg 3) and plakins. Autoantibodies against desmoglein 3 in sera of...